HAB You Heard
Series of webinars for Ryan White HIV/AIDS Program (RWHAP) agencies, by HRSA's HIV/AIDS Bureau.
Resource updated 03/07/2024
Series of webinars for Ryan White HIV/AIDS Program (RWHAP) agencies, by HRSA's HIV/AIDS Bureau.
Resource updated 03/07/2024
Webinars and other special events by HRSA's HIV/AIDS Bureau.
Resource updated 01/09/2024
Resource updated 03/15/2023
Table linking HRSA HAB performance indicators to clinician training resources developed by HRSA programs.
Resource updated 01/31/2024
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 02/11/2021
Staff will present a population-based, data-driven approach to the Minority AIDS Initiative (MAI) funding designed to improve program engagement and retention to reduce health disparities and maximize health outcomes. Presenters will review methods to facilitate replication of the model in other Ryan White programs.
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
The session will discuss lessons learned from the Rhode Island's path to the AIDS Drugs Assistance Program (ADAP) automation through the implementation of the Lifia Portal. The Lifia portal is a tool designed to manage client enrollment, eligibility and benefits, streamline and take an ADAP program to the next level.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
The Alabama Quality Management Group (AQMG) is a consortium of quality leaders representing all Alabama RWHAP Part C and D clinics, over 80% of Alabama's HIV-diagnosed population. Data for Care Alabama (D4C-AL), a CDC-funded retention-in-care project, uses risk-stratification based on missed visits. It is currently being implemented at one site but will continue to be implemented over time.
Resource (Conference Presentation) updated 09/14/2023
This session will describe how the integration of a patient navigator program and a Management Information System led to increased rates across the HIV continuum of care in a single-provider clinic in El Paso, Texas.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
Staff from the Massachusetts Department of Public Health and CRI will present the fundamentals, best practices, and innovations for their clinical quality management (CQM) program that aimed to improve timely enrollment and retention in the AIDS Drug Assistance Program (ADAP). The presentation will include an overview of the transition to self-attestation and how organizational change supported a quality-driven approach.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023